Ivacaftor-treated Patients with Cystic Fibrosis Derive Long-Term Benefit Despite No Short-Term Clinical Improvement

Eitemau Tebyg

• Pseudomonas aeruginosa in Cystic Fibrosis Patients With G551D-CFTR Treated With Ivacaftor
  gan: Heltshe, Sonya L., et al.
  Cyhoeddwyd: (2015)
• Growth in Prepubertal Children With Cystic Fibrosis Treated With Ivacaftor
  gan: Stalvey, Michael S., et al.
  Cyhoeddwyd: (2017)
• Females with Cystic Fibrosis Demonstrate a Differential Response Profile to Ivacaftor Compared with Males
  gan: Secunda, Katharine E., et al.
  Cyhoeddwyd: (2020)
• Effectiveness of ivacaftor in cystic fibrosis Patients with non-G551D gating mutations
  gan: Guimbellot, Jennifer, et al.
  Cyhoeddwyd: (2018)
• Combination Therapy with Lumacaftor–Ivacaftor in Cystic Fibrosis. Keeping It Real
  gan: Sala, Marc A., et al.
  Cyhoeddwyd: (2020)